NUVEMZI
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2024)
What this means for you
This application is over — abandoned 08 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88578889
- Mark type
- Stylized text
- Filed
- 14 Aug 2019
- Published for opposition
- 18 Feb 2020
- Abandoned
- 08 Jan 2024
- Attorney of record
- DANNY M AWDEH
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
Owner
- Ovid Therapeutics Inc., New York, NY, US
- Ovid Therapeutics Inc., New York, NY, US
Prosecution history
- 08 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2023 — SOU EXTENSION 5 GRANTED
- 06 Jun 2023 — SOU EXTENSION 5 FILED
- 12 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2022 — SOU EXTENSION 4 GRANTED
- 30 Nov 2022 — SOU EXTENSION 4 FILED
- 30 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jun 2022 — SOU EXTENSION 3 GRANTED
- 08 Jun 2022 — SOU EXTENSION 3 FILED
- 08 Jun 2022 — SOU TEAS EXTENSION RECEIVED